About Cereius

About company

Cereius, Inc. is a privately owned, pre-clinical stage company developing novel approaches to treating sold tumor brain metastasis. Cereius’ novel radiolabeling chemistries increase the uptake and retention of radionuclides in the target tumor while minimizing uptake by normal tissues, significantly enhancing the therapeutic index and diagnostic contrast of targeting agents.